Altre lingue Lifecore Biomedical, Inc.

Azioni

LFCR

US5147661046

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 24/04/2024			Variaz. 5gg	Var. 1 gen.
6,33 ^USD	-2,01%		-3,06%	+2,26%

01/04	Lifecore Biomedical, Inc. Fornisce una guida alle entrate per l'intero anno fiscale 2024	CI
27/03	Lifecore Biomedical cerca un nuovo revisore per l'anno fiscale 2024	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lifecore Biomedical, Inc. - LFCR	20/04
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC	20/04
Lifecore Biomedical Gets Nasdaq Warning Over Delayed Quarterly Report	19/04
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report	19/04
LFCR INVESTOR NEWS: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC	13/04
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lifecore Biomedical, Inc. - LFCR	12/04
ROSEN, A TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC	11/04
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lifecore Biomedical, Inc. - LFCR	05/04
Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress	01/04
Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress	01/04
Lifecore Biomedical, Inc. Provides Revenue Guidance for Full Year Fiscal 2024	01/04
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors	28/03
Law Offices of Howard G. Smith Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors	28/03
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	28/03
Lifecore Biomedical Searches for New Auditor for Fiscal Year 2024	27/03
The Law Offices of Frank R. Cruz Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors	27/03
Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update	26/03
Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update	26/03
Lifecore Class Action Lawsuit Investigation News – Potential to Make Claim, Recover Losses, Contact Johnson Fistel, LLP	24/03
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	21/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Lifecore Biomedical, Inc.

Azioni

LFCR

US5147661046

Altre lingue

Filtri